erythrosine has been researched along with (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choy, E; Duan, Z; Hornicek, FJ | 1 |
1 other study(ies) available for erythrosine and (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol
Article | Year |
---|---|
NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluoresceins; Humans; Models, Chemical; Ovarian Neoplasms; Paclitaxel; Piperidines; Quinolines | 2009 |